2021–22 Departmental Plan: Health Canada
Description
Health Canada will also continue to identify and acquire COVID-19 treatments and therapies; expedite regulatory reviews of drugs, medical devices and disinfectants; procure any needed medical and personal protective equipment; prioritize the review of COVID-19 tests, including new, innovative options and technologies; and pursue strategies to expand testing capacity.
Resources
| Name |
Format |
Description |
Link |
| 2021–22 Departmental Plan: Health Canada |
HTML |
|
https://www.canada.ca/en/health-canada/corporate/transparency/corporate-management-reporting/report-plans-priorities/2021-2022-report-plans-priorities.html |
| 2021–22 Departmental Plan: Health Canada |
HTML |
|
https://www.canada.ca/fr/sante-canada/organisation/transparence/rapports-gestion/rapport-plans-priorites/2021-2022-rapport-plans-priorites.html |